Wall Street analysts seem pretty gung-ho about Realty Income, pegging an average price target at $68 per share, a significant pop from where the stock sits now. That’s in addition to a dividend yield north of 6%.
Is Wall Street right or is the recent selloff indicative of what’s to come for Realty Income?
» Read more about: Spotlight: 1 High-paying Dividend Stock Is Way Undervalued »
Did you know that man would never have landed on the moon without a company that flies under the radar, called Analog Devices. Its data converters were used in the Apollo Lunar Lander, and today they play a role in everything from smartphones to autonomous vehicles.
DigitalOcean is no ordinary cloud computing firm as you’ll see but it is down by 30% over the past 6 months, and yet appears to have significant upside potential from here.
If you’re not familiar with it, the company is like AWS or Google Cloud, but for small to medium-sized businesses (SMBs). Developers like it because of its…
It’s impossible to discuss Moderna without mentioning its COVID-19 vaccine, which propelled the stock to record highs in 2021 approaching $500 per share. However, slower sales caused the stock to plunge by almost 80%.
Second-quarter reports in 2023 show a net loss of $1.38 billion, a stark contrast to the net income of $5.4 billion in Q4 2021.
» Read more about: Spotlight: Time To Buy Vaccine Manufacturer Before Winter? »
In my view, Verizon’s generous dividend isn’t just stable, it’s on track to climb even higher. As it stands, Verizon offers a tantalizing dividend yield of 7.9%, a figure amplified by the recent dip in its stock price. The stock has lost about a fifth of its value from its peak over the past 52 weeks,
» Read more about: Market Commentary: Is This 7.9% Dividend Real? »
Cathie Wood has been investing heavily in Verve Therapeutics (VERV), a company developing therapies for cardiovascular diseases. So what’s all the fuss about? We took a deeper dive to find out.
Warren Buffett is one of the most successful investors of all time. He has made billions of dollars by following a simple investment philosophy: invest in companies with strong competitive advantages that are trading at fair prices.
One of Buffett’s favorite companies is Apple now represents an astonishing 51% of his entire stock portfolio.
» Read more about: 51% Of Buffett’s Portfolio Is In 1 Stock »
Warren Buffett may be old but he’s fearless when it comes to making massive bets. One such outsized investment is Apple, which now represents close to 50% of his equity portfolio (see below).
Imagine having so much conviction in a single company that you allocate half your money to it. Now further consider having a portfolio the size of Buffett’s and making that same bet.
» Read more about: Market Commentary: Buffett Loaded Up On 1 Stock Every Quarter For 5 Years »
TransMedics (NASDAQ:TMDX) has emerged as a prominent player in the medical field, witnessing a remarkable surge from $14 to $90 in a little over 18 months.
The company’s core expertise lies in organ care systems, which preserve transplant organs post-donor retrieval.
Have you ever been to a public restroom and wondered how the company that runs the soap dispensary fares? If not, let me lift the veil. If so, you may already be familiar with the name Cintas.
Cintas Corporation (NASDAQ:CTAS) is a leading provider of restroom supplies,
» Read more about: Spotlight: 1 Stunning Stock To Hold For 10 Years »